Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | ALDH1A1 | P00352 | 3/20 | 0.51 |
| ▸ | LMNA | P02545 | 1/20 | 0.51 |
| ▸ | POLB | P06746 | 1/20 | 0.51 |
| ▸ | APOBEC3A | P31941 | 2/20 | 0.36 |
| ▸ | APOBEC3G | Q9HC16 | 2/20 | 0.36 |
| ▸ | ALOX15 | P16050 | 1/20 | 0.33 |
| ▸ | CTNNB1 | P35222 | 1/20 | 0.33 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL713031 | 0.79 | ALDH1A1 (0.56) | ALDH1A1LMNAPOLBAPOBEC3AAPOBEC3G | |
| SCHEMBL15137817 | 0.79 | ALDH1A1 (0.51) | ALDH1A1LMNAPOLBAPOBEC3AAPOBEC3G | |
| SCHEMBL14359784 | 0.69 | ALDH1A1 (0.44) | ALDH1A1LMNAPOLBAPOBEC3AAPOBEC3G | |
| SCHEMBL20608586 | 0.69 | ALDH1A1 (0.40) | ALDH1A1LMNAPOLBAPOBEC3AAPOBEC3G | |
| SCHEMBL10708498 | 0.68 | POLB (1.00) | ALDH1A1LMNAPOLBAPOBEC3AAPOBEC3G | |
| SCHEMBL719071 | 0.65 | ALDH1A1 (0.42) | ALDH1A1LMNAPOLBAPOBEC3AAPOBEC3G | |
| SCHEMBL27967573 | 0.64 | ALDH1A1 (0.43) | ALDH1A1LMNAPOLBAPOBEC3AAPOBEC3G | |
| SCHEMBL20608612 | 0.62 | ALDH1A1 (0.43) | ALDH1A1LMNAPOLBAPOBEC3AAPOBEC3G | |
| SCHEMBL29827662 | 0.62 | ALDH1A1 (0.43) | ALDH1A1LMNAPOLBAPOBEC3AAPOBEC3G | |
| SCHEMBL4329831 | 0.62 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-102471739-B | Process for preparing perfume particles | THE PROCTER & GAMBLE CO. (US) | 2016-05-11 | — | — | CN | disclosed |